CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 87 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,626,000 | -12.8% | 114,659 | -1.5% | 0.00% | +50.0% |
| Q4 2017 | $3,010,000 | +71.4% | 116,356 | -2.3% | 0.00% | 0.0% |
| Q3 2017 | $1,756,000 | +5.1% | 119,066 | -0.6% | 0.00% | 0.0% |
| Q2 2017 | $1,671,000 | -19.2% | 119,750 | -1.2% | 0.00% | 0.0% |
| Q1 2017 | $2,067,000 | +59.2% | 121,172 | -3.9% | 0.00% | +100.0% |
| Q4 2016 | $1,298,000 | -13.2% | 126,128 | -14.7% | 0.00% | 0.0% |
| Q3 2016 | $1,495,000 | -16.8% | 147,847 | -7.6% | 0.00% | -50.0% |
| Q2 2016 | $1,796,000 | -13.5% | 159,968 | +5.2% | 0.00% | 0.0% |
| Q1 2016 | $2,077,000 | -33.3% | 152,050 | -7.3% | 0.00% | -50.0% |
| Q4 2015 | $3,112,000 | -13.7% | 164,073 | -14.6% | 0.00% | 0.0% |
| Q3 2015 | $3,608,000 | – | 192,210 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,050,124 | $10,312,000 | 3.31% |
| Alambic Investment Management, L.P. | 19,934 | $196,000 | 2.15% |
| INGALLS & SNYDER LLC | 1,363,603 | $13,391,000 | 0.92% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,946,000 | 0.80% |
| RA Capital Management | 1,858,474 | $18,250,000 | 0.33% |
| Perceptive Advisors | 2,150,641 | $21,119,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 310,000 | $3,044,000 | 0.30% |
| Eversept Partners, LP | 103,829 | $1,019,601 | 0.23% |
| Opaleye Management Inc. | 100,000 | $982,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 58,095 | $570,000 | 0.10% |